XERS vs PAHC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

XERS

47.1
AI Score
VS
XERS Wins

PAHC

44.5
AI Score

Investment Advisor Scores

XERS

47score
Recommendation
HOLD

PAHC

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XERS PAHC Winner
Revenue 1.12B 175.23M PAHC
Net Income 78.01M -28.87M PAHC
Net Margin 7.0% -16.5% PAHC
Operating Income 146.24M 13.09M PAHC
ROE 21.6% 296.6% XERS
ROA 5.4% -7.0% PAHC
Total Assets 1.45B 411.90M PAHC
Cash 54.93M 121.75M XERS
Debt/Equity 1.71 -25.95 XERS
Current Ratio 3.17 1.45 PAHC

Relative Price Performance (Last 90 Days)

XERS 1M: -12.2% · 3M: +7.5% PAHC 1M: +5.4% · 3M: +13.9%

Current Technical Phase

XERS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.0 · Price: $7.45

PAHC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.7 · Price: $35.62

Fundamentals Snapshot

Metric XERS PAHC
Market Cap
Forward P/E 19.1 10.7
Trailing P/E 15.1
Revenue (TTM)
Revenue Growth 0.3% 0.0%
Gross Margin 0.9% 0.3%
Operating Margin 0.1% 0.1%
EPS -0.10 2.42
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, XERS is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.